(PRESS RELEASE) PARIS, 12-Jan-2023 — /EuropaWire/ — AXA (EPA: CS), a French multinational insurance and asset management firm, has announced that it has renewed the mandate of the AXA Research Fund for five years. The fund, one of the largest … Read the full press release
Posted in Business, Financial, France, Insurance, Investment, Non Profit, Science, Society
Tagged academic experts, AXA, emerging risks, Marie Bogataj, philanthropy, Professor Debra Roberts, Professor Thomas Kirkwood, researchers, scientific knowledge, scientific philanthropy, societal issues, THOMAS BUBERL, Ulrike Decoene
(PRESSEMITTEILUNG) PARIS, 12-Jan-2023 — /EuropaWire/ — AXA (EPA: CS), ein französisches multinationales Versicherungs- und Vermögensverwaltungsunternehmen, hat bekannt gegeben, dass es das Mandat des AXA Research Fund um fünf Jahre verlängert hat. Der Fonds, eine der größten wissenschaftlichen Philanthropie-Initiativen im Privatsektor, … Read the full press release
Posted in Business, Financial, France, Insurance, Investment, Non Profit, Science, Society
Tagged academic experts, AXA, emerging risks, Forscher, Marie Bogataj, Philanthropie, Professor Debra Roberts, Professor Thomas Kirkwood, scientific knowledge, Society Issues, THOMAS BUBERL, Ulrike Decoene, Wissenschaftliche Philanthropie
5-7-2013 — /europawire.eu/ — AXA pursues its commitment towards independent academic research by adding €100 million to the AXA Research Fund budget for the period 2013 to 2018. This amount tops the initial €100 million granted to the AXA Research Fund … Read the full press release
Posted in Financial, France, Investment, Non Profit, Science
Tagged AXA, AXA Research Fund, Henri de Castries, Professor Thomas Kirkwood
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
